adaptive biotech is working to develop the best antibody treatment for covid-19: ceo
Published 4 years ago • 2.1K plays • Length 3:53Download video MP4
Download video MP3
Similar videos
-
7:16
adaptive biotechnologies ceo on partnership with microsoft to study coronavirus
-
3:15
adaptive biotech t-cell test receives fda approval for emergency use
-
5:26
adaptive biotechnologies ceo on covid-19 research efforts, russia vaccine claims
-
3:23
covid-19 antibody treatment needs to be scaled up: doctor
-
6:18
adaptive biotechnologies ceo on the company's ipo and pipeline
-
5:19
cramer: this biotech stock could be worth over $100 billion on an fda approval
-
3:06
adaptive's new headquarters
-
7:06
crispr co-founder jennifer doudna on future of biotech
-
3:25
biotech firms race to develop coronavirus diagnostic tools, treatment and vaccinations
-
5:16
developing antibodies for covid-19
-
46:12
covid-19 insights: monoclonal antibodies
-
2:11
adaptive biotechnologies’ immune medicine platform
-
3:04
vancouver biotech firm looking for a covid-19 cure
-
6:11
the next breakthroughs in biotech
-
9:43
how understanding t cells could change medicine
-
4:48
time to double down on biotech?
-
8:48
covid-19 therapeutics will be available before a vaccine, says 10x genomics ceo
-
3:10
how biotech firms plan to ensure diversity in covid-19 vaccine trials
-
1:02:22
covid-19 t-cell data: mapping out sars- cov-2 antigen & t-cell repertoires
-
9:26
behind the bell: adaptive biotechnology
-
1:07
adaptive biotechnologies doubles in public debut
-
3:17
why these biotech, pharma stocks have more upside: analyst